Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer.
Guillén Díaz-Maroto N, Sanz-Pamplona R, Berdiel-Acer M, Cimas FJ, García E, Gonçalves-Ribeiro S, Albert N, Garcia-Vicién G, Capella G, Moreno V, Salazar R, Villanueva A, Molleví DG. Guillén Díaz-Maroto N, et al. Among authors: cimas fj. Clin Cancer Res. 2019 Jul 15;25(14):4466-4479. doi: 10.1158/1078-0432.CCR-18-3957. Epub 2019 Apr 12. Clin Cancer Res. 2019. PMID: 30979739
TRIB1 regulates tumor growth via controlling tumor-associated macrophage phenotypes and is associated with breast cancer survival and treatment response.
Kim T, Johnston J, Castillo-Lluva S, Cimas FJ, Hamby S; Cardiogenics Consortium*; Gonzalez-Moreno S, Villarejo-Campos P, Goodall AH, Velasco G, Ocana A, Muthana M, Kiss-Toth E. Kim T, et al. Among authors: cimas fj. Theranostics. 2022 Apr 24;12(8):3584-3600. doi: 10.7150/thno.72192. eCollection 2022. Theranostics. 2022. PMID: 35664073 Free PMC article.
ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma.
Arias-González L, Moreno-Gimeno I, del Campo AR, Serrano-Oviedo L, Valero ML, Esparís-Ogando A, de la Cruz-Morcillo MÁ, Melgar-Rojas P, García-Cano J, Cimas FJ, Hidalgo MJ, Prado A, Callejas-Valera JL, Nam-Cha SH, Giménez-Bachs JM, Salinas-Sánchez AS, Pandiella A, del Peso L, Sánchez-Prieto R. Arias-González L, et al. Among authors: cimas fj. Neoplasia. 2013 Jun;15(6):649-59. doi: 10.1593/neo.121896. Neoplasia. 2013. PMID: 23730213 Free PMC article.
Abrogation of the p38 MAPK α signaling pathway does not promote radioresistance but its activity is required for 5-Fluorouracil-associated radiosensitivity.
de la Cruz-Morcillo MA, García-Cano J, Arias-González L, García-Gil E, Artacho-Cordón F, Ríos-Arrabal S, Valero ML, Cimas FJ, Serrano-Oviedo L, Villas MV, Romero-Fernández J, Núñez MI, Sánchez-Prieto R. de la Cruz-Morcillo MA, et al. Among authors: cimas fj. Cancer Lett. 2013 Jul 10;335(1):66-74. doi: 10.1016/j.canlet.2013.01.050. Epub 2013 Feb 8. Cancer Lett. 2013. PMID: 23403078
Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance.
García-Cano J, Ambroise G, Pascual-Serra R, Carrión MC, Serrano-Oviedo L, Ortega-Muelas M, Cimas FJ, Sabater S, Ruiz-Hidalgo MJ, Sanchez Perez I, Mas A, Jalón FA, Vazquez A, Sánchez-Prieto R. García-Cano J, et al. Among authors: cimas fj. Oncotarget. 2015 Jun 20;6(17):15551-65. doi: 10.18632/oncotarget.3902. Oncotarget. 2015. PMID: 26036632 Free PMC article.
MKP1: Jekyll and Hyde for E1A.
Cimas FJ, Callejas-Valera JC, Sanchez-Prieto R. Cimas FJ, et al. Aging (Albany NY). 2016 Feb;8(2):214-5. doi: 10.18632/aging.100918. Aging (Albany NY). 2016. PMID: 26977801 Free PMC article. No abstract available.
E1a is an exogenous in vivo tumour suppressor.
Cimas FJ, Callejas-Valera JL, García-Olmo DC, Hernández-Losa J, Melgar-Rojas P, Ruiz-Hidalgo MJ, Pascual-Serra R, Ortega-Muelas M, Roche O, Marcos P, Garcia-Gil E, Fernandez-Aroca DM, Ramón Y Cajal S, Gutkind JS, Sanchez-Prieto R. Cimas FJ, et al. Cancer Lett. 2017 Jul 28;399:74-81. doi: 10.1016/j.canlet.2017.04.010. Epub 2017 Apr 15. Cancer Lett. 2017. PMID: 28416454
29 results